CASTLE BIOSCIENCES INC Quarterly Interest Expense in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Castle Biosciences Inc quarterly/annual Interest Expense history and growth rate from Q2 2018 to Q3 2024.
  • Castle Biosciences Inc Interest Expense for the quarter ending September 30, 2024 was $192K, a 9500% increase year-over-year.
  • Castle Biosciences Inc Interest Expense for the twelve months ending September 30, 2024 was $424K, a 3162% increase year-over-year.
  • Castle Biosciences Inc annual Interest Expense for 2023 was $11K, a 35.3% decline from 2022.
  • Castle Biosciences Inc annual Interest Expense for 2022 was $17K, a 1600% increase from 2021.
  • Castle Biosciences Inc annual Interest Expense for 2021 was $1K, a 100% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $424K $192K +$190K +9500% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $234K $216K +$213K +7100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $21K $14K +$10K +250% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $11K $2K -$2K -50% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $13K $2K -$4K -66.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $17K $3K -$1K -25% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $18K $4K +$1K +33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $17K $4K +$3K +300% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $14K $6K +$6K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $8K $4K +$4K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $4K $3K +$3K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $1K $1K -$394K -99.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $395K $0 -$706K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $1.1M $0 -$769K -100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.87M $0 -$764K -100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $2.63M $395K -$371K -48.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $3.01M $706K -$382K -35.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $3.39M $769K -$924K -54.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $4.31M $764K -$260K -25.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $4.57M $766K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $1.09M +$519K +91.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.69M +$1.17M +223% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.02M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $569K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $525K Apr 1, 2018 Jun 30, 2018 10-Q 2019-09-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.